Medical Oncology

Vitiligo

Questions discussed in this category

How do you manage new-onset vitiligo in a patient on immune checkpoint inhibitors?

Do you hold ICI, prescribe steroids, or refer to dermatology, and does your approach vary between curative, adjuvant, or metastatic settings?

3 Answers available

Papers discussed in this category

The New England journal of medicine, 2022 Oct 20

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.

JAAD case reports, 2024 Nov 26

Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanoma.

MedComm, 2025 Mar 04

Combining JAK Inhibitors with Immune Checkpoint Inhibitors: Overcoming Resistance in Cancer Treatment.

Related Topics in Medical Oncology